• 1
    Ali R, Barnes I, Cairns BJ, Finlayson AE, Bhala N, Mallath M, Beral V. Incidence of gastrointestinal cancers by ethnic group in England, 2001–2007. Gut. 2012 Oct 23 [Epub ahead of print].
  • 2
    Hu Y, Fang JY, Xiao SD. Is it possible to further reduce the incidence of gastric cancer in the new century? J Dig Dis. 2013; 14: 1115.
  • 3
    Tang Y, Dai Y, Huo J. Decreased expression of T-cadherin is associated with gastric cancer prognosis. Hepatogastroenterology. 2012; 59: 12941298.
  • 4
    Zhao ZS, Wang YY, Chu YQ, Ye ZY, Tao HQ. SPARC is associated with gastric cancer progression and poor survival of patients. Clin Cancer Res. 2010; 16: 260268.
  • 5
    Zhao HC, Qin R, Chen XX, Sheng X, Wu JF, Wang DB, Chen GH. Microvessel density is a prognostic marker of human gastric cancer. World J Gastroenterol. 2006; 12: 75987603.
  • 6
    Emara M, Cheung PY, Grabowski K, Sawicki G, Wozniak M. Serum levels of matrix metalloproteinase-2 and -9 and conventional tumor markers (CEA and CA 19-9) in patients with colorectal and gastric cancers. Clin Chem Lab Med. 2009; 47: 9931000.
  • 7
    Liu T, Liu D, Liu J, Song JT, Gao SL, Li H, Hu LH, Liu BR Effect of NF-kappaB inhibitors on the chemotherapy-induced apoptosis of the colon cancer cell line HT-29. Exp Ther Med. 2012; 4: 716722.
  • 8
    Ghosh A, Saginc G, Leow SC, Khattar E, Shin EM, Yan TD, Wong M, Zhang Z, Li G, Sung WK, et al. Telomerase directly regulates NF-kappaB-dependent transcription. Nat Cell Biol. 2012; 14: 12701281.
  • 9
    Zhu G, Yin F, Deng X. Effect of NF-kappaB on inhibition of non-small cell lung cancer cell cyclooxygenase-2 by brucine. Zhongguo Zhong Yao Za Zhi. 2012; 37: 12691273.
  • 10
    Gagliardo R, Chanez P, Mathieu M, Bruno A, Costanzo G, Gougat C, Vachier I, Bousquet J, Bonsignore G, Vignola AM. Persistent activation of nuclear factor-kappaB signaling pathway in severe uncontrolled asthma. Am J Respir Crit Care Med. 2003; 168: 11901198.
  • 11
    Ren Z, Cui J, Huo Z, Xue J, Cui H, Luo B, Jiang L, Yang R. Cordycepin suppresses TNF-alpha-induced NF-kappaB activation by reducing p65 transcriptional activity, inhibiting IkappaBalpha phosphorylation, and blocking IKKgamma ubiquitination. Int Immunopharmacol. 2012; 14: 698703.
  • 12
    Wu SY, Leu YL, Chang YL, Wu TS, Kuo PC, Liao YR, Teng CM, Pan SL. Physalin F induces cell apoptosis in human renal carcinoma cells by targeting NF-kappaB and generating reactive oxygen species. PLoS ONE. 2012; 7: e40727.
  • 13
    Tian F, Zhang C, Tian W, Jiang Y, Zhang X. Comparison of the effect of p65 siRNA and curcumin in promoting apoptosis in esophageal squamous cell carcinoma cells and in nude mice. Oncol Rep. 2012; 28: 232240.
  • 14
    Lafarge S, Hamzeh-Cognasse H, Richard Y, Pozzetto B, Cogne M, Cognasse F, Garraud O. Complexes between nuclear factor-kappaB p65 and signal transducer and activator of transcription 3 are key actors in inducing activation-induced cytidine deaminase expression and immunoglobulin A production in CD40L plus interleukin-10-treated human blood B cells. Clin Exp Immunol. 2011; 166: 171183.
  • 15
    Cao HJ, Fang Y, Zhang X, Chen WJ, Zhou WP, Wang H, Wang LB, Wu JM. Tumor metastasis and the reciprocal regulation of heparanase gene expression by nuclear factor kappa B in human gastric carcinoma tissue. World J Gastroenterol. 2005; 11: 903907.
  • 16
    Sasaki N, Morisaki T, Hashizume K, Yao T, Tsuneyoshi M, Noshiro H, Nakamura K, Yamanaka T, Uchiyama A, Tanaka M, et al. Nuclear factor-kappaB p65 (RelA) transcription factor is constitutively activated in human gastric carcinoma tissue. Clin Cancer Res. 2001; 7: 41364142.
  • 17
    Guo XL, Ma NN, Zhou FG, Zhang L, Bu XX, Sun K, Song JR, Li R, Zhang BH, Wu MC, et al. Up-regulation of hTERT expression by low-dose cisplatin contributes to chemotherapy resistance in human hepatocellular cancer cells. Oncol Rep. 2009; 22: 549556.
  • 18
    Kojima M, Morisaki T, Sasaki N, Nakano K, Mibu R, Tanaka M, Katano M. Increased nuclear factor-kB activation in human colorectal carcinoma and its correlation with tumor progression. Anticancer Res. 2004; 24: 675681.
  • 19
    Biondi A, Hyung WJ. Seventh edition of TNM classification for gastric cancer. J Clin Oncol. 2011; 29: 43384339; author reply 4340–4342.
  • 20
    Starska K, Forma E, Lewy-Trenda I, Stasikowska O, Brys M, Krajewska WM, Lukomski M. The expression of SOCS1 and TLR4-NFkappaB pathway molecules in neoplastic cells as potential biomarker for the aggressive tumor phenotype in laryngeal carcinoma. Folia Histochem Cytobiol. 2009; 47: 401410.
  • 21
    Bendinelli P, Matteucci E, Maroni P, Desiderio MA. NF-kappaB activation, dependent on acetylation/deacetylation, contributes to HIF-1 activity and migration of bone metastatic breast carcinoma cells. Mol Cancer Res. 2009; 7: 13281341.
  • 22
    Djordjevic G, Matusan-Ilijas K, Sinozic E, Damante G, Fabbro D, Grahovac B, Lucin K, Jonjic N. Relationship between vascular endothelial growth factor and nuclear factor-kappaB in renal cell tumors. Croat Med J. 2008; 49: 608617.
  • 23
    Yamanaka N, Sasaki N, Tasaki A, Nakashima H, Kubo M, Morisaki T, Noshiro H, Yao T, Tsuneyoshi M, Tanaka M, et al. Nuclear factor-kappaB p65 is a prognostic indicator in gastric carcinoma. Anticancer Res. 2004; 24: 10711075.
  • 24
    Asoglu O, Karanlik H, Parlak M, Kecer M, Muslumanoglu M, Igci A, Ozmen V, Gulluoglu M, Kapran Y. Metastatic lymph node ratio is an independent prognostic factor in gastric cancer. Hepatogastroenterology. 2009; 56: 908913.
  • 25
    Baiocchi G, Begnami MD, Fukazawa EM, Oliveira RA, Faloppa CC, Kumagai LY, Badiglian-Filho L, Pellizzon AC, Maia MA, Jacinto AA, et al. Prognostic value of nuclear factor kappa B expression in patients with advanced cervical cancer undergoing radiation therapy followed by hysterectomy. J Clin Pathol. 2012; 65: 614618.
  • 26
    Li J, Wang K, Chen X, Meng H, Song M, Wang Y, Xu X, Bai Y. Transcriptional activation of microRNA-34a by NF-kappa B in human esophageal cancer cells. BMC Mol Biol. 2012; 13: 4.
  • 27
    Visconti R, Cerutti J, Battista S, Fedele M, Trapasso F, Zeki K, Miano MP, deNigris F, Casalino L, Curcio F, et al. Expression of the neoplastic phenotype by human thyroid carcinoma cell lines requires NFkappaB p65 protein expression. Oncogene. 1997; 15: 19871994.
  • 28
    Subramaniam D, Giridharan P, Murmu N, Shankaranarayanan NP, May R, Houchen CW, Ramanujam RP, Balakrishnan A, Vishwakarma RA, Anant S. Activation of apoptosis by 1-hydroxy-5,7-dimethoxy-2-naphthalene-carboxaldehyde, a novel compound from Aegle marmelos. Cancer Res. 2008; 68: 85738581.